By Cassie M. Chew ( January 8, 2024, 8:09 PM EST) -- Prior to its initial public offering, executives of Kenvue and its former parent company, Johnson & Johnson, failed to inform investors that there were questions about the efficacy of phenylephrine, a decongestant used in several brands of Kenvue's over-the-counter medicines, a shareholder said in a complaint filed Monday in New Jersey district court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.